By Julia Karow

Broadening its DNA target enrichment portfolio beyond SureSelect, Agilent Technologies last week acquired Halo Genomics of Uppsala, Sweden, for an undisclosed amount.

Privately held Halo, which changed its name from Olink Genomics earlier this year, offers single-tube multiplex target amplification, based on a method that was originally developed at Uppsala University. The method, which relies on so-called selector probes, can amplify up to several thousand genomic targets per reaction.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.